DPP4 and diabetes mellitus: Dipeptidyl peptidase-IV (DPP-IV) inhibitors, often known as gliptins, are a class of oral anti-diabetic medications that have been given approval by the Food and Drug Administration (FDA) to treat individuals with type 2 diabetes mellitus (T2DM) [1].